Stock News

Entellus Medical, Inc. (ENTL) Reaches $23.85 After 6.00% Up Move; Harley-Davidson, Inc. (HOG) Had 5 Bulls

Among 25 analysts covering Harley-Davidson (NYSE:HOG), 5 have Buy rating, 1 Sell and 19 Hold. Therefore 20% are positive. Harley-Davidson had 81 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Neutral” rating by Goldman Sachs given on Monday, June 6. As per Monday, January 11, the company rating was downgraded by Raymond James. RBC Capital Markets maintained Harley-Davidson, Inc. (NYSE:HOG) on Wednesday, April 19 with “Sector Perform” rating. On Wednesday, October 21 the stock rating was maintained by Deutsche Bank with “Hold”. The firm earned “Sector Perform” rating on Friday, January 15 by RBC Capital Markets. Jefferies initiated the stock with “Hold” rating in Friday, September 30 report. The stock has “Sector Perform” rating by RBC Capital Markets on Monday, January 18. The company was maintained on Wednesday, October 19 by Stifel Nicolaus. The stock of Harley-Davidson, Inc. (NYSE:HOG) earned “Outperform” rating by Bernstein on Friday, September 9. As per Wednesday, April 5, the company rating was maintained by RBC Capital Markets. See Harley-Davidson, Inc. (NYSE:HOG) latest ratings:

29/10/2017 Broker: RBC Capital Markets Rating: Hold New Target: $49.0 Maintain
20/10/2017 Broker: Argus Research Old Rating: Hold New Rating: Buy Upgrade
18/10/2017 Broker: Stifel Nicolaus Rating: Hold New Target: $49.0 Maintain
18/10/2017 Broker: Morgan Stanley Rating: Buy New Target: $54.0
13/10/2017 Broker: Goldman Sachs Rating: Hold
13/10/2017 Broker: BMO Capital Markets Rating: Buy New Target: $56.0 Maintain
06/10/2017 Broker: Wedbush Rating: Hold New Target: $45.0
24/09/2017 Broker: RBC Capital Markets Rating: Hold New Target: $49.0 Maintain
13/09/2017 Broker: UBS Rating: Hold New Target: $47.0 Maintain
30/08/2017 Broker: KeyBanc Capital Markets Rating: Hold

The stock of Entellus Medical, Inc. (NASDAQ:ENTL) is a huge mover today! The stock increased 48.97% or $7.84 during the last trading session, reaching $23.85. About 5.57M shares traded or 4120.92% up from the average. Entellus Medical, Inc. (NASDAQ:ENTL) has declined 17.59% since December 7, 2016 and is downtrending. It has underperformed by 34.29% the S&P500.The move comes after 8 months positive chart setup for the $607.56 million company. It was reported on Dec, 7 by Barchart.com. We have $25.28 PT which if reached, will make NASDAQ:ENTL worth $36.45 million more.

Investors sentiment decreased to 0.91 in Q2 2017. Its down 0.09, from 1 in 2017Q1. It fall, as 52 investors sold Harley-Davidson, Inc. shares while 157 reduced holdings. 53 funds opened positions while 137 raised stakes. 153.33 million shares or 4.67% more from 146.48 million shares in 2017Q1 were reported. Comm Savings Bank stated it has 5,020 shares or 0% of all its holdings. Benjamin F Edwards Co accumulated 8,872 shares. Rhumbline Advisers accumulated 0.04% or 332,647 shares. Bluemountain Cap Limited Liability accumulated 0.06% or 56,618 shares. Heritage Mngmt Corp reported 114,607 shares or 0.42% of all its holdings. Nationwide Fund Advsr has 49,829 shares for 0.01% of their portfolio. Hudock Capital Grp Inc Ltd Liability Company has invested 0% in Harley-Davidson, Inc. (NYSE:HOG). Basswood Mgmt Ltd Limited Liability Company holds 1.2% or 454,214 shares in its portfolio. Bank Of Nova Scotia has invested 0.02% in Harley-Davidson, Inc. (NYSE:HOG). State Street Corp reported 0.04% stake. Northern Trust holds 0.03% in Harley-Davidson, Inc. (NYSE:HOG) or 1.99 million shares. Hartford Invest Mngmt reported 0.04% of its portfolio in Harley-Davidson, Inc. (NYSE:HOG). Moreover, Horrell Capital has 0% invested in Harley-Davidson, Inc. (NYSE:HOG) for 147 shares. Archford Strategies Ltd Llc has invested 0.02% of its portfolio in Harley-Davidson, Inc. (NYSE:HOG). Cambiar Ltd Liability Com invested 0.05% of its portfolio in Harley-Davidson, Inc. (NYSE:HOG).

The stock decreased 0.35% or $0.18 during the last trading session, reaching $50.7. About 254,950 shares traded. Harley-Davidson, Inc. (NYSE:HOG) has risen 20.11% since December 7, 2016 and is uptrending. It has outperformed by 3.41% the S&P500.

Harley-Davidson, Inc. primarily manufactures and sells cruiser and touring motorcycles. The company has market cap of $8.46 billion. The firm operates through two divisions, Motorcycles & Related Products, and Financial Services. It has a 15.82 P/E ratio. The Motorcycles & Related Products segment designs, makes, and sells wholesale on-road Harley-Davidson motorcycles, as well as motorcycle parts, accessories, general merchandise, and related services.

Entellus Medical, Inc., a medical technology company, focuses on the design, development, and commercialization of products for the minimally invasive treatment of patients suffering from chronic and recurrent sinusitis. The company has market cap of $607.56 million. The firm offers XprESS Multi-Sinus Dilation family of products consisting of XprESS Pro device, XprESS LoProfile device, and XprESS Ultra device, which open an obstructed or narrowed drainage pathway of a sinus cavity by means of trans-nasal balloon sinus dilation. It currently has negative earnings. It also provides PathAssist tools, such as LED Light Fiber, a single-use tool that provides real-time high intensity red trans-illumination of the sinus cavity with its battery power; Light Fiber, a single-use tool that provides real-time trans-illumination of the sinus cavity; Light Seeker, a tool with optical fibers embedded into the device to allow ear, nose, and throat physicians to access the frontal sinus and trans-illuminate the sinus cavity; Maxillary Seeker, a tool that allow users to find the correct angle to access the natural maxillary ostia; and Sphenoid Seeker/Freer, a two-in-one tool that enables ENT physicians to navigate access to the sphenoid ostium.

Among 5 analysts covering Entellus Medical (NASDAQ:ENTL), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Entellus Medical had 8 analyst reports since August 9, 2015 according to SRatingsIntel. BTIG Research initiated Entellus Medical, Inc. (NASDAQ:ENTL) on Tuesday, June 14 with “Buy” rating. Piper Jaffray maintained the shares of ENTL in report on Tuesday, September 29 with “” rating. The rating was maintained by Canaccord Genuity on Monday, October 16 with “Hold”. The firm has “Buy” rating given on Thursday, October 6 by Deutsche Bank. The rating was maintained by Piper Jaffray with “Buy” on Monday, August 21. The rating was maintained by Canaccord Genuity on Sunday, August 9 with “Buy”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *